XPA-210: a new proliferation marker to characterize tumor biology and progression of renal cell carcinoma

Authors:

Abstract
Recent lung cancer data have shown an association of XPA-210, a key peptide of thymidine kinase, with advanced disease. We thus assessed its proliferation status in primary (M0) and metastatic (M1) renal cell carcinoma (RCC).

This publication has 25 references indexed in Scilit: